Get the Stockscreener App
2.64
4.69%
-0.13
After Hours:
2.70
0.06
+2.27%
Ainos Inc stock is traded at $2.64, with a volume of 264.51K.
It is down -4.69% in the last 24 hours and up +422.36% over the past month.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
See More
Previous Close:
$2.77
Open:
$2.79
24h Volume:
264.51K
Relative Volume:
1.14
Market Cap:
$11.07M
Revenue:
$93,700
Net Income/Loss:
$-16.13M
P/E Ratio:
-0.9429
EPS:
-2.8
Net Cash Flow:
$-6.32M
1W Performance:
-8.33%
1M Performance:
+422.36%
6M Performance:
+329.27%
1Y Performance:
+252.00%
1-Day Range:
$2.55
$2.8514
1-Week Range:
$2.55
$2.88
52-Week Range:
$0.40
$3.35
Ainos Inc Stock (AIMD) Company Profile
Name
Ainos Inc
Sector
Industry
Phone
858-869-2986
Address
AINOS, INC., SAN DIEGO
Compare AIMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AIMD
Ainos Inc
|
2.64 | 12.07M | 93,700 | -16.13M | -6.32M | -2.80 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Ainos Inc Stock (AIMD) Latest News
Ainos Inc. Equity Warrant Stock Analysis and ForecastSkyrocketing profit margins - Autocar Professional
What drives Ainos Inc. stock priceRecord-breaking gains - Autocar Professional
Ainos Inc. Stock Analysis and ForecastExplosive market performance - jammulinksnews.com
What analysts say about Ainos Inc. Equity Warrant stockDynamic investment opportunities - PrintWeekIndia
Is Ainos Inc. Equity Warrant a good long term investmentMassive portfolio appreciation - Autocar Professional
What drives Ainos Inc. Equity Warrant stock priceDynamic investment growth - Autocar Professional
Is Ainos Inc. a good long term investmentSignificant capital appreciation - Autocar Professional
What analysts say about Ainos Inc. stockFree Smart Trading Workshop - PrintWeekIndia
Ainos (OTCMKTS:AIMD) Trading Down 1.1% – Here’s Why - Defense World
What makes Ainos Inc. Equity Warrant stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
Will Ainos Inc. stock benefit from AI tech trendsVolume Spike Monitors - Newser
What institutions are buying Ainos Inc. Equity Warrant stock nowFree Stock Investment Discussion Area - Newser
Ainos Regains Nasdaq Compliance, Eyes AI Expansion - The Globe and Mail
Why Ainos Inc. Equity Warrant stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser
Financial Review: Ainos (NASDAQ:AIMD) vs. Pyxis Oncology (NASDAQ:PYXS) - Defense World
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street - Sentinel-Standard
AI Breakthrough: Ainos Digital Smell Platform Achieves 90% Accuracy, Plans 15,000 Unit Rollout in Next 90 Days - Stock Titan
Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026 - The Globe and Mail
Ainos regains Nasdaq compliance - TipRanks
How Ainos Inc. Equity Warrant stock performs during market volatilitySmall Risk Large Return Trades - Newser
Why Ainos Inc. stock attracts strong analyst attentionPotential Rocket List - Newser
What makes Ainos Inc. stock price move sharplyFree Best Stocks to Buy Today - Newser
How Ainos Inc. stock performs during market volatilityHigh Return Potential - Newser
Ainos Inc Stock (AIMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):